Related references
Note: Only part of the references are listed.LESS IS MORE Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation
Morten L. Hansen et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Comparison of Different Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Drug-Eluting Stent Implantation
Fei Gao et al.
CIRCULATION JOURNAL (2010)
Comparison of ticagrelor with clopidogrel in patients with planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
Christopher P. Cannon et al.
LANCET (2010)
Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents.
Seung-Jung Park et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/Stenting A Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association [EHRA] and the European Association of Percutaneous Cardiovascular Interventions [EAPCI]
Gregory Y. H. Lip et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Prevention of cardioembolic stroke in patients with atrial fibrillation
Ralph Weber et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2010)
Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation
Takeshi Kimura et al.
CIRCULATION (2009)
Combining Antiplatelet and Anticoagulant Therapies
David R. Holmes et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Frederick G. Kushner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial
Gilles Montalescot et al.
LANCET (2009)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation
Andrea Rubboli et al.
ANNALS OF MEDICINE (2008)
Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention - The prasugrel in comparison to clopidogrel for inhibition of platelet activation and aggregation-thrombolysis in myocardial infarction 44 trial
Stephen D. Wiviott et al.
CIRCULATION (2007)
Major Hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation
Elaine M. Hylek et al.
CIRCULATION (2007)
Antiplatelet treatment for coronary heart disease
N. Clappers et al.
HEART (2007)
Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: An exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials
Greg C. Flaker et al.
AMERICAN HEART JOURNAL (2006)
Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence
Yoko Miyasaka et al.
CIRCULATION (2006)
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
DL Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Long-term anticoagulant therapy in patients with coronary artery disease
SE Husted et al.
EUROPEAN HEART JOURNAL (2006)
Avoiding central nervous system bleeding during antithrombotic therapy recent - Data and ideas
RG Hart et al.
STROKE (2005)
Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy
DM Witt et al.
CHEST (2005)
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
HC Diener et al.
LANCET (2004)
Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation
MC Fang et al.
ANNALS OF INTERNAL MEDICINE (2004)
Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients
TI Shireman et al.
STROKE (2004)
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention - A randomized controlled trial
SR Steinhubl et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Warfarin, aspirin, or both after myocardial infarction.
M Hurlen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial
RF van Es et al.
LANCET (2002)
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
SR Mehta et al.
LANCET (2001)
Analysis of risk factors involved in oral-anticoagulant-related intracranial haemorrhages
J Berwaerts et al.
QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS (2000)